Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window

Ann Transl Med. 2017 Dec;5(23):464. doi: 10.21037/atm.2017.09.10.

Authors

Shauna L French¹, Justin R Hamilton¹

Affiliation

¹ Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.

No abstract available

Publication types

Editorial
Comment